UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to
Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
| |
| enVVeno Medical Corporation |
| (Name of Registrant as Specified in Its Charter) |
| |
| N/A |
| (Name of Person(s) Filing Proxy Statement, if Other than the Registrant) |
| |
Payment of Filing Fee (Check the appropriate box):
| | | | |
| ☒ | | | No fee required. |
| | | | |
| ☐ | | | Fee paid previously with preliminary materials. |
| | | | |
| ☐ | | | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
| | | | |
